Final results from the NRG-BR002 trial provide important evidence against routinely adding metastasis-directed treatment in patients with oligometastatic breast cancer when systemic therapy is controlling the disease. @Docace911@NRGonc
https://t.co/HNqPrJ3uKU
After decades of declining incidence rates, new data shows that colorectal cancer rates are rising for the first time among all age groups - not just in young people. Read our full story: https://t.co/Dcdp2WwTmX
A UChicago Medicine clinical trial gave Naperville mom Kerrie Watson access to a promising new pancreatic cancer drug. For Pancreatic Cancer Awareness Month, read Kerrie's story and learn what this treatment could mean for the future of care. https://t.co/VtXr1vUpp3
Researchers at @MassGeneralNews and @UChicago are studying how to improve access to lung cancer screening among Black individuals. What they learn could help expand eligibility requirements so that more people can get screened. Learn more: https://t.co/t3KNbwgqWG #lcsm#LCAM 🫁
A recent @NEJMEvidence study reports rising colorectal cancer rates not only in younger population but also in older age groups, cautioning a heavy burden on the healthcare system for cancer treatment and survivorship care. #CancerScreening#CancerRisks
https://t.co/8dMJE910Te
@UChicago researchers found that radiation can push immune cells into protecting tumors instead of attacking them through a protein called TET2, and that blocking it flips those cells into cancer fighters. @rweichselbaum@Ludwig_Cancer@UChiChemistry
https://t.co/fklXWexJNY
There's still time to register for our 5th Annual Chicago Gynecologic Cancer Researcher Survivor summit!
Sat, 11/14
8:30 AM -1:00 PM
University of Chicago Medicine
Center for Care & Discovery 7th Floor Boardroom
5700 S Maryland Ave Chicago
RSVP here: https://t.co/YhYPsJpFk3
This Saturday, our Hyde Park and Orland Park locations are offering appointments for National Lung Cancer Screening Day, a nationwide effort to make lung cancer screening more accessible. To get started, call 773-702-2290 or visit https://t.co/0P3P9IKckY #LCSDay2026#lcsm#LCAM
Congratulations to David Tuveson, MD, PhD, Executive Director of Duke Cancer Institute, on receiving the 2026 Simon M. Shubitz Cancer Prize! 🎉
Today he shared how research is moving us toward better medicine for pancreatic cancer. #ShubitzPrize#PancreaticCancer#CancerResearch
Dr. Youssef Comair, a UChicago Medicine neurosurgeon and Chief of Neuro-Oncology, explains symptoms that require immediate attention, treatment options and how a specialized team approach can help protect brain function. Read more: https://t.co/PaRh4clgdq
new publication featuring Dr Kosuri as co-author which looks at an oral biotherapeutic targeting the GI microbiome in patients undergoing allo-transplant!
https://t.co/X2fsqQjp9m
Meet Dr. Stanley Liauw, MD, a radiation oncologist and an educator at @UChicagoMed. His outcomes research, drawn from more than 2,000 patients, is helping reduce the side effects and refine care across many cancers. #FollowFriday@oncostan@UChicagoRadonc
https://t.co/5mbD9olSDh
A LPL patient’s heart kept racing dangerously, and nothing worked. Lymphoma had invaded the nerves controlling his heart beat. @UChicagoMed oncologists, cardiologists, and surgeons teamed up to perform a targeted surgery. He remains complication-free now.
https://t.co/k7wSucQv4E